INR 45.08
(-3.74%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.98 Billion INR | -4.44% |
2022 | 4.1 Billion INR | 10.38% |
2021 | 3.71 Billion INR | 23.72% |
2020 | 3 Billion INR | 22.08% |
2019 | 2.46 Billion INR | 7.1% |
2018 | 2.29 Billion INR | 16.24% |
2017 | 1.97 Billion INR | 10.01% |
2016 | 1.79 Billion INR | 13.7% |
2015 | 1.58 Billion INR | 9.14% |
2014 | 1.44 Billion INR | -2.49% |
2013 | 1.48 Billion INR | 5.86% |
2012 | 1.4 Billion INR | 4.08% |
2011 | 1.34 Billion INR | 77.83% |
2010 | 757.69 Million INR | 13.21% |
2009 | 669.26 Million INR | -6.41% |
2008 | 715.1 Million INR | -10.52% |
2007 | 799.15 Million INR | 0.57% |
2006 | 794.6 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 635.58 Million INR | 78.67% |
2023 Q2 | 1.23 Billion INR | 1.25% |
2023 Q3 | 1.3 Billion INR | 5.93% |
2023 Q4 | 964.94 Million INR | -26.0% |
2023 Q1 | 1.21 Billion INR | 6.0% |
2023 FY | 3.91 Billion INR | -4.44% |
2022 Q4 | 1.14 Billion INR | 9.84% |
2022 Q3 | 1.04 Billion INR | -1.26% |
2022 FY | 4.1 Billion INR | 10.38% |
2022 Q1 | 853.08 Million INR | -13.13% |
2022 Q2 | 1.05 Billion INR | 23.97% |
2021 FY | 3.71 Billion INR | 23.72% |
2021 Q2 | 873.59 Million INR | 7.99% |
2021 Q3 | 1.05 Billion INR | 20.35% |
2021 Q1 | 808.98 Million INR | -2.57% |
2021 Q4 | 982.01 Million INR | -6.6% |
2020 Q2 | 725.24 Million INR | 9.3% |
2020 Q1 | 663.51 Million INR | 26.78% |
2020 FY | 3 Billion INR | 22.08% |
2020 Q4 | 830.32 Million INR | 5.16% |
2020 Q3 | 789.57 Million INR | 8.87% |
2019 Q3 | 659.87 Million INR | 3.28% |
2019 FY | 2.46 Billion INR | 7.1% |
2019 Q4 | 523.36 Million INR | -20.69% |
2019 Q1 | 607.33 Million INR | 12.7% |
2019 Q2 | 638.89 Million INR | 5.2% |
2018 Q4 | 538.91 Million INR | -14.6% |
2018 FY | 2.29 Billion INR | 16.24% |
2018 Q3 | 631.01 Million INR | 11.03% |
2018 Q1 | 559.1 Million INR | 5.67% |
2018 Q2 | 568.35 Million INR | 1.65% |
2017 Q2 | 476.84 Million INR | -3.86% |
2017 FY | 1.97 Billion INR | 10.01% |
2017 Q3 | 474.75 Million INR | -0.44% |
2017 Q4 | 529.08 Million INR | 11.44% |
2017 Q1 | 495.97 Million INR | 0.0% |
2016 FY | 1.79 Billion INR | 13.7% |
2015 FY | 1.58 Billion INR | 9.14% |
2014 FY | 1.44 Billion INR | -2.49% |
2013 FY | 1.48 Billion INR | 5.86% |
2012 Q1 | - INR | 0.0% |
2012 Q3 | - INR | 0.0% |
2012 Q4 | - INR | 0.0% |
2012 FY | 1.4 Billion INR | 4.08% |
2012 Q2 | - INR | 0.0% |
2011 FY | 1.34 Billion INR | 77.83% |
2010 FY | 757.69 Million INR | 13.21% |
2009 FY | 669.26 Million INR | -6.41% |
2008 FY | 715.1 Million INR | -10.52% |
2007 FY | 799.15 Million INR | 0.57% |
2006 FY | 794.6 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -13883.325% |
Aarti Drugs Limited | 1.16 Billion INR | -70.234% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 35.355% |
Ajanta Pharma Limited | 30.46 Billion INR | 93.476% |
Alembic Limited | 872.45 Million INR | -127.799% |
Alkem Laboratories Limited | 32.83 Billion INR | 93.947% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 87.476% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 19.65% |
Bal Pharma Limited | 555.62 Million INR | -257.696% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -29041.496% |
Bliss GVS Pharma Limited | 1.41 Billion INR | -40.038% |
Brooks Laboratories Limited | 51.18 Million INR | -3783.255% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | -336.241% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 8.602% |
Divi's Laboratories Limited | 14.17 Billion INR | 85.974% |
Eris Lifesciences Limited | 4.94 Billion INR | 59.792% |
Granules India Limited | 10.31 Billion INR | 80.728% |
Ind-Swift Limited | 946.56 Million INR | -109.964% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -353.187% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 86.565% |
Jubilant Pharmova Limited | 14.45 Billion INR | 86.25% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -381.891% |
Medicamen Biotech Limited | 335.16 Million INR | -492.973% |
Medico Remedies Limited | 59.67 Million INR | -3230.457% |
Wockhardt Limited | 8.48 Billion INR | 76.563% |
Orchid Pharma Limited | 800.77 Million INR | -148.192% |
RPG Life Sciences Limited | 1.63 Billion INR | -21.519% |
Shilpa Medicare Limited | 3.33 Billion INR | 40.392% |
Sigachi Industries Limited | 579.88 Million INR | -242.731% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 22.186% |
Unichem Laboratories Limited | 6.72 Billion INR | 70.451% |
Vaishali Pharma Limited | 84.02 Million INR | -2265.195% |
Wanbury Limited | 978.96 Million INR | -103.015% |
Zydus Lifesciences Limited | 125.21 Billion INR | 98.413% |
FDC Limited | 3.49 Billion INR | 43.212% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 5.09% |
Bajaj HealthCare Limited | 985.34 Million INR | -101.701% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 97.927% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 82.927% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 6.437% |
Laurus Labs Limited | 11.9 Billion INR | 83.312% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -1125.097% |
Nectar Lifesciences Limited | 932.7 Million INR | -113.086% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -3309.706% |
Hester Biosciences Limited | 908.84 Million INR | -118.68% |
Ipca Laboratories Limited | 18.98 Billion INR | 89.533% |
Venus Remedies Limited | 1.91 Billion INR | -3.714% |
ZIM Laboratories Limited | 1.01 Billion INR | -96.183% |
Aurobindo Pharma Limited | 55.65 Billion INR | 96.429% |
Neuland Laboratories Limited | 2.92 Billion INR | 32.163% |
Sequent Scientific Limited | 2.9 Billion INR | 31.51% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | -41.678% |
Valiant Laboratories Limited | 138.02 Million INR | -1339.879% |
Windlas Biotech Limited | 1 Billion INR | -97.46% |
Hikal Limited | 4.46 Billion INR | 55.476% |
Innova Captab Limited | 931.03 Million INR | -113.468% |
Procter & Gamble Health Limited | 2.99 Billion INR | 33.65% |
Themis Medicare Limited | 1.12 Billion INR | -76.537% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 9.702% |
Mankind Pharma Limited | 29.27 Billion INR | 93.211% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 95.767% |
Sakar Healthcare Limited | 204.07 Million INR | -873.863% |
Albert David Limited | 1.02 Billion INR | -93.681% |
Lupin Limited | 125.09 Billion INR | 98.411% |
Gufic Biosciences Limited | 1.18 Billion INR | -67.493% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 98.711% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -85.019% |
Syncom Formulations (India) Limited | 345.63 Million INR | -475.017% |
Piramal Enterprises Limited | 63.65 Billion INR | 96.878% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 90.722% |
NATCO Pharma Limited | 10.05 Billion INR | 80.24% |
Suven Life Sciences Limited | 109.75 Million INR | -1710.888% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -4205.941% |
Strides Pharma Science Limited | 9.16 Billion INR | 78.308% |
Indoco Remedies Limited | 12.06 Billion INR | 83.522% |
Alpa Laboratories Limited | 127.38 Million INR | -1460.253% |
Lasa Supergenerics Limited | 291.17 Million INR | -582.564% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 35.405% |